This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Patients should be advised to stop drinking because of:

  • depressant effects of alcohol on heart muscle
  • difficulty in diagnosing alcohol-induced cardiomyopathy

Treatment of cardiac failure:

  • treatment with angiotensin converting enzyme (ACE) inhibitors and beta blockers in line with management of chronic cardiac failure
  • diuretics for management of symptoms with congestion; digoxin may also be required

Anti-arrhythmic drugs:

  • only necessary if symptomatic arrhythmias or ventricular ectopics are so frequent as to impair cardiac output
  • amiodarone is the agent of choice

Anticoagulation:

  • long-term anticoagulation is the rule rather than the exception for most patients
  • is mandatory if there is co-existent atrial fibrillation

Other treatment options include cardiac transplantation and cardiomyoplasty.

Notes:

  • if refractory symptoms and left bundle branch block then patient may benefit from a biventricular pacemaker (2)
  • should be considered for an implantable cardioverter defibrillator
  • patients with syncope (with or without documented ventricular arrhythmias) identifies a high risk cohort (2)

Reference:

  1. British Heart Foundation (1999). Factfile 1/99, Dilated Cardiomyopathy.
  2. Pulse (May 28th 2005): 54-61.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.